CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

From New Orleans, the Latest Advances in Orthopedics

Published: Fri, 20 Apr 2018 12:02:47 EDT
Dr Frank A. Cordasco reviews highlights from the American Academy of Orthopaedic Surgeons 2018 Annual Meeting.
Hospital for Special Surgery

Higher LDL, CV Risk Magnify Expected LDL-Lowering Clinical Gains

Published: Fri, 20 Apr 2018 11:58:04 EDT
The observation can inform shared decision-making when clinicians are considering intensified LDL-cholesterol management, for example, adding PCSK9 inhibitors to statins, say researchers.
Medscape Medical News

Experimental Drug Takes on Injury From Fatty Liver

Published: Fri, 20 Apr 2018 11:29:43 EDT
An investigative human fibroblast growth factor 19 analog is in development to reduce markers of liver damage in patients with nonalcoholic steatohepatitis.
Medscape Medical News
Displaying results 10-12 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Tmunity dials series A round up to $135M to fuel progress of T-cell immunotherapy pipeline

Published: Thu, 19 Apr 2018 12:34:23 +0000
Tmunity has added $35 million to its series A round, bringing its total haul up to $135 million. The cash sets ex-Novartis executive Usman “Oz” Azam up to build out the infrastructure Tmunity needs to hustle its pipeline of T cell-based immunotherapies through clinical development.

Novartis lures John Tsai from Amgen to fill CMO seat

Published: Thu, 19 Apr 2018 10:41:29 +0000
Vas Narasimhan, M.D., has persuaded John Tsai, M.D., to fill the vacant CMO role at Novartis. Tsai took up the same position at Amgen just 11 months ago but had his head turned by the digitally enabled pipeline Narasimhan is building at Novartis.

Novartis’ Jay Bradner bemoans 'redundant investment in the biotech sector' for some cancer R&D

Published: Thu, 19 Apr 2018 09:21:24 +0000
Jay Bradner, president of Novartis’ Institutes for BioMedical Research, questions whether billions in cancer research funding is going in the right direction as he points out a “flood of fast followers, narrow differentiators and distracting hype” around some new therapies and research.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top